We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
-17.1%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.69B
AUM Growth
-$1.36B
Cap. Flow
-$72.7M
Cap. Flow %
-1.28%
Top 10 Hldgs %
17.58%
Holding
1,139
New
165
Increased
376
Reduced
380
Closed
175

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$58.3M
2
CELG
Celgene Corp
CELG
+$27.6M
3
BMY icon
Bristol-Myers Squibb
BMY
+$23.3M
4
TJX icon
TJX Companies
TJX
+$23.1M
5
SNPS icon
Synopsys
SNPS
+$19.9M

Sector Composition

Rank Sector Weight
1 Technology 19.85%
2 Financials 17.71%
3 Consumer Discretionary 12.6%
4 Healthcare 11.49%
5 Industrials 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSDO
751
DELISTED
Presidio, Inc. Common Stock
PSDO
$449K 0.01%
+34,375
New +$476K
REX icon
752
REX American Resources
REX
$1.46B
$448K 0.01%
+39,486
New +$463K
SYKE
753
DELISTED
SYKES Enterprises Inc
SYKE
$445K 0.01%
17,998
+10,930
+155% +$305K
GTS
754
DELISTED
Triple-S Management Corporation
GTS
$444K 0.01%
26,827
-17,995
-40% -$312K
ALTR
755
DELISTED
Altair Engineering Inc
ALTR
$442K 0.01%
+16,040
New +$529K
VECO icon
756
Veeco
VECO
$3.15B
$441K 0.01%
59,506
+8,600
+17% +$73.5K
PFS icon
757
Provident Financial Services
PFS
$3.11B
$435K 0.01%
18,029
-5,500
-23% -$133K
STML
758
DELISTED
Stemline Therapeutics, Inc.
STML
$431K 0.01%
+45,413
New +$589K
TIVO
759
DELISTED
Tivo Inc
TIVO
$430K 0.01%
+45,724
New +$493K
CCBG icon
760
Capital City Bank Group
CCBG
$882M
$428K 0.01%
18,424
-704
-4% -$17K
ACHN
761
DELISTED
Achillion Pharmaceuticals
ACHN
$426K 0.01%
267,613
+36,500
+16% +$103K
FCF icon
762
First Commonwealth Financial
FCF
$2.12B
$424K 0.01%
35,100
-4,100
-10% -$56.3K
ZIXI
763
DELISTED
Zix Corporation
ZIXI
$422K 0.01%
+73,608
New +$439K
VATE icon
764
INNOVATE Corp
VATE
$114M
$419K 0.01%
+15,870
New +$669K
CHH icon
765
Choice Hotels
CHH
$5.03B
$417K 0.01%
5,820
ARWR icon
766
Arrowhead Research
ARWR
$12.1B
$416K 0.01%
33,500
MOFG
767
DELISTED
MidWestOne Financial Group
MOFG
$407K 0.01%
16,380
+450
+3% +$13.2K
EEX
768
DELISTED
Emerald Holding
EEX
$406K 0.01%
+32,893
New +$426K
TILE icon
769
Interface
TILE
$1.91B
$406K 0.01%
28,472
-24,028
-46% -$413K
ECVT icon
770
Ecovyst
ECVT
$1.36B
$405K 0.01%
+27,360
New +$420K
HNI icon
771
HNI Corp
HNI
$3B
$405K 0.01%
11,420
+920
+9% +$34.9K
QLYS icon
772
Qualys
QLYS
$4.84B
$405K 0.01%
5,420
-600
-10% -$45.2K
VYNE icon
773
VYNE Therapeutics
VYNE
$340K
$399K 0.01%
+27
New +$604K
FBMS
774
DELISTED
The First Bancshares, Inc.
FBMS
$390K 0.01%
+12,888
New +$450K
LTS
775
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$384K 0.01%
164,619
-26,476
-14% -$70.9K

Similar funds

Jacobs Levy Equity Management's Q4 2018 Portfolio in Review

As of Q4 2018, Jacobs Levy Equity Management held 1,139 positions worth $5.69B, down 19% from $7.05B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Jacobs Levy Equity Management's Q4 2018 filing shows 165 new, 376 increased, 380 reduced and 175 closed positions. Its largest new stake was Starbucks: 930,980 shares worth $60M. The largest sale was Dell, an estimated $45.2M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Jacobs Levy Equity Management's largest Q4 2018 buy was Starbucks: 930,980 shares worth $60M.
  • Jacobs Levy Equity Management added most to Celgene Corp in Q4 2018, an estimated $27.6M increase.
  • Jacobs Levy Equity Management's biggest Q4 2018 reduction was Accenture, cutting an estimated $24M.
  • Jacobs Levy Equity Management fully exited Dell in Q4 2018, selling an estimated $45.2M.
  • Jacobs Levy Equity Management's ten largest holdings make up 18% of its $5.69B portfolio in Q4 2018.
  • Jacobs Levy Equity Management opened 165 new positions and closed 175 in Q4 2018.
  • Jacobs Levy Equity Management's portfolio value fell 19% quarter-over-quarter to $5.69B.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2018, filed 14 Feb 2019.